[Triptolide induces autophagy of ovarian granulosa cells via PI3K/AKT/m TOR pathway]

Jun Bai1, Ye-Ke Wu2, Ke-Ming Wu2

  • 1Affiliated Hospital of Shaanxi University of Chinese Medicine Xianyang 712000,China.

Insights

Triptolide (TP) effectively induces autophagy in ovarian granulosa cells (OGCs) at a concentration of 100 nmol·L-1 for 12 hours. This process is mediated by inhibiting the PI3K/Akt/mTOR signaling pathway, offering insights into TP

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Reproductive Biology

Background:

  • Ovarian granulosa cells (OGCs) play a crucial role in ovarian function.
  • Autophagy is a vital cellular process implicated in various physiological and pathological conditions.
  • Triptolide (TP) is a compound with known biological activities, but its effect on OGC autophagy requires elucidation.

Purpose of the Study:

  • To investigate the concentration, time, and mechanism of autophagy induction by triptolide (TP) in ovarian granulosa cells (OGCs).
  • To determine the effective concentration and duration for TP-induced autophagy in OGCs.
  • To elucidate the molecular pathway involved in TP-mediated autophagy in OGCs.

Main Methods:

  • Cell viability was assessed using the CCK-8 assay to determine the IC50 of TP on primary cultured rat OGCs.
  • Western blot analysis was employed to detect the expression levels of autophagy-related proteins (beclin1, LC3) and the PI3K/Akt/mTOR signaling pathway components.
  • Comparative analysis was performed using TP, an autophagy inducer (brefeldin A), and a PI3K/mTOR inhibitor (NVP-BEZ235).

Main Results:

  • The IC50 of TP on rat OGCs was determined to be 14.65 μmol·L-1, with a minimum inhibitory concentration of 0.1 μmol·L-1 (100 nmol·L-1).
  • TP treatment significantly upregulated the expression of autophagy markers beclin1 and LC3-II while downregulating LC3-I and p62.
  • TP inhibited the phosphorylation of PI3K, Akt, and mTOR, suggesting a mechanism involving the suppression of the PI3K/Akt/mTOR pathway.

Conclusions:

  • Triptolide (TP) at 100 nmol·L-1 effectively induces autophagy in cultured rat ovarian granulosa cells (OGCs) within 12 hours.
  • TP-induced autophagy in OGCs appears to be mediated through the inhibition of the PI3K/Akt/mTOR signaling pathway.
  • These findings provide novel insights into the cellular mechanisms of TP action in ovarian cells.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
1.9K